• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Luitpold Pharmaceuticals

Anonymous board for Luitpold Pharmaceuticals
Replies
14
Views
3K
anonymous
Replies
0
Views
616
anonymous
Replies
3
Views
2K
anonymous
Replies
5
Views
7K
Former Long time employee
Replies
1
Views
2K
anonymous
Replies
3
Views
3K
anonymous
Replies
0
Views
4K
anonymous
Replies
4
Views
4K
anonymous
Replies
0
Views
3K
anonymous
Replies
1
Views
3K
anonymous
Replies
19
Views
8K
anonymous
Replies
2
Views
3K
anonymous
Replies
2
Views
3K
anonymous
Replies
9
Views
3K
anonymous
Replies
2
Views
4K
Anonymous
Replies
42
Views
23K
Anonymous